Stage III colorectal cancer with metastasis to the lungs is classified as Stage IV?
Thank you for taking the time to respond to my inquiry on March 8th.
Currently, I have white spots in both lungs, so surgery is not an option.
After three months of treatment with second-line medications, there has been no change.
The tumor I had surgically removed tested positive, but the CT scan report indicates stability, which means I cannot apply for third-line targeted therapy covered by health insurance.
My doctor has given me three options for subsequent chemotherapy, and I feel very anxious and frustrated as I lack the professional knowledge to make a judgment.
I would like to ask for your better advice.
The three options provided by my doctor are as follows:
1.
Monitor the situation and wait for the disease to worsen before applying for insurance coverage (which would allow for a change in medication).
As the doctor mentioned previously, there is a chance of metastasis within the three-month follow-up period.
2.
Continue with the current second-line treatment (including chemotherapy agents such as Gemcitabine, Pemetrexed, and Bevacizumab) as a single regimen.
I am concerned about the potential for developing drug resistance, which could lead to a deterioration that would allow me to apply for targeted therapy covered by insurance.
3.
Switch to a self-funded regimen (changing to third-line medications: Gemcitabine, Erlotinib, and Bevacizumab) administered weekly.
Please note that my insurance has a limit of 100,000 TWD for 15 days and only covers hospitalization.
Fen, 40~49 year old female. Ask Date: 2011/04/19
Dr. Chen Sirong reply Oncology
Fen/45/1 I apologize! My personal expertise is in radiation oncology and palliative care, so your question should be directed to a physician specialized in chemotherapy for a more accurate response, which is why my reply is delayed.
Essentially, your attending physician's advice is reasonable, and how to choose really depends on your personality and your understanding of your condition.
1.
Lung metastasis means that treatment can only control the disease and not cure it.
2.
However, current medications do extend patients' lives.
3.
Therefore, most patients continue treatment: if first-line therapy fails, they move to second-line, and if second-line fails, they proceed to third-line.
4.
Ultimately, treatment continues until there are no more options available or the patient's physical condition cannot tolerate further treatment, at which point they enter palliative care to alleviate suffering.
This is an inevitable process.
How to allow your spiritual perspective to reflect on this natural process of life and death, and to experience it in accordance with circumstances while maintaining inner peace, is more important than constantly worrying about your illness.
The physician's professional explanation has clarified things for you, and now you must decide your own path.
Ultimately, all paths lead to the same destination.
The key is to accept your experiences in the moment (this is my choice, and I am willing to take responsibility for it).
1.
You can take advantage of your good physical condition to travel abroad and temporarily forget about your illness, which can be beneficial.
2.
If you are still concerned but do not wish to spend money, you may have to choose option 2.
3.
If you are very uneasy and prefer to spend money on treatment, then choose option 3.
Please discuss this with your family.
I wish you peace and coexistence with every part of your body.
Sincerely, Chen Si-Rong
Reply Date: 2011/04/19
More Info
Navigating treatment options for Stage IV colorectal cancer with lung metastasis can be an overwhelming experience, especially when faced with multiple choices and the complexities of cancer treatment. It’s essential to understand the implications of each option and how they align with your overall health goals and preferences.
Understanding Your Current Situation
From your description, it seems that you have undergone two lines of treatment, and while the tumor was removed and tested positive, the CT scan indicates stability. This suggests that while the cancer has not progressed significantly, it has not improved either. The presence of "white spots" in your lungs is concerning, as it indicates potential metastasis, which complicates treatment decisions.
Treatment Options
1. Watchful Waiting (Surveillance): This option involves monitoring your condition without immediate treatment. The idea is to wait until there are signs of disease progression before starting a new treatment. While this may seem like a passive approach, it can be beneficial if the cancer is stable. However, the risk is that cancer can progress during this period, and you may miss the opportunity for timely intervention.
2. Continuation of Current Second-Line Treatment: Continuing with your current regimen (anti-cancer drugs) may provide some benefits, especially if you are tolerating the treatment well. However, there is a concern about developing resistance to the drugs over time, which could limit future treatment options. If you choose this route, regular monitoring is crucial to assess the effectiveness of the treatment.
3. Switching to Third-Line Treatment (Out-of-Pocket): Opting for a third-line treatment with a different combination of drugs could potentially offer a new avenue for managing your cancer. While this option requires out-of-pocket expenses, it may provide a chance for better outcomes if the current treatment is not effective. It’s important to discuss the potential benefits and side effects of these new medications with your oncologist.
Factors to Consider
- Quality of Life: Consider how each treatment option will impact your quality of life. Some treatments may have significant side effects that could affect your daily activities and overall well-being.
- Financial Implications: Evaluate your financial situation regarding out-of-pocket expenses for the third-line treatment. It’s essential to balance the potential benefits of a new treatment with the financial burden it may impose.
- Consultation with Your Healthcare Team: Engage in open discussions with your oncologist and healthcare team. They can provide insights into the likelihood of success for each option based on your specific case, including tumor characteristics and your overall health.
- Support Systems: Consider involving family members or support groups in your decision-making process. They can provide emotional support and help you weigh the pros and cons of each option.
Conclusion
Ultimately, the decision on how to proceed with your treatment should align with your personal values, health goals, and the advice of your healthcare team. It’s crucial to feel empowered in your decision-making process, even when faced with difficult choices. Remember that you are not alone in this journey, and there are resources available to help you navigate your treatment options effectively. Regular follow-ups and open communication with your oncologist will be key in managing your condition and making informed decisions about your care.
Similar Q&A
Understanding Stage IV Colon Cancer: Treatment Options and Metastasis Insights
My mother was unfortunately diagnosed with stage IV colon cancer this year, which has metastasized to the lungs. Due to her condition, she cannot undergo surgery and is currently receiving chemotherapy and targeted therapy. Recently, the tumor has shrunk, and the medical oncologi...
Dr. Cai Jinji reply Gastroenterology and Hepatology
Dear Ms. Li, I am not very clear about your mother's condition. I recommend discussing it further with your doctor. Alternatively, you could obtain a copy of her medical records and schedule an appointment for a consultation, which would provide a clearer understanding. ...[Read More] Understanding Stage IV Colon Cancer: Treatment Options and Metastasis Insights
Surgical Treatment Options for Stage IV Lung Adenocarcinoma: Risks and Benefits
Director Huang, I would like to seek your expertise regarding my mother, who is 68 years old. In January 2017, a CT scan revealed a 2 cm tumor in the lower right lung. Follow-up biopsies and Tc-99m MDP scans confirmed stage IV lung adenocarcinoma with metastasis to the ribs and v...
Dr. Huang Yiwen reply Pulmonology
DEAR AKIRA: Stage IV lung cancer is generally inoperable; however, if there is downstaging after targeted therapy, surgery is certainly recommended as it tends to have a higher survival rate. If surgery is not an option, there are many medications available for lung adenocarcinom...[Read More] Surgical Treatment Options for Stage IV Lung Adenocarcinoma: Risks and Benefits
Understanding Stage 4 Colon Cancer Treatment: Chemotherapy and Targeted Therapy
Dear Dr. Chen, My husband, Cheng-Chung, was diagnosed with stage IV colorectal cancer (metastatic colorectal cancer) in May 2021. A CT scan on May 11 at National Taiwan University Hospital revealed liver metastases, with multiple small tumors, approximately 7-8 in total, the lar...
Dr. Chen Yunfang reply Oncology
Hello: For stage IV colorectal cancer, according to current standard treatment, the first-line therapy consists of chemotherapy combined with the targeted drug Avastin. Based on previous research findings, the expected probability of tumor shrinkage is over 50%. The average durat...[Read More] Understanding Stage 4 Colon Cancer Treatment: Chemotherapy and Targeted Therapy
Managing Stage IV Rectal Cancer: Treatment Options and Prognosis
Hello Doctor: My mother has stage IV rectal cancer, and recently three tumors approximately 1-3 cm in size were found on her liver. Her CEA level is 45. Since she has already used several medications, we decided to use Cetuximab, along with 5-FU and CPT-11 weekly, and Cetuximab w...
Dr. Chen Sirong reply Oncology
Hello: 1. I agree with this physician's approach. 2. I am not optimistic; I suggest you discuss the efficacy of Oxaliplatin with your attending physician. Sincerely, Dr. Chen Sih-Rong, Oncology.[Read More] Managing Stage IV Rectal Cancer: Treatment Options and Prognosis
Related FAQ
(Oncology)
Terminal Stage(Oncology)
Colon Cancer(Oncology)
Cancer Treatment(Oncology)
Colorectal Cancer(Surgery)
Pancreatic Cancer(Oncology)
Bile Duct Cancer(Oncology)
Colorectal Cancer(Gastroenterology and Hepatology)
Palliative Care(Oncology)
Nasopharyngeal Cancer(Oncology)